{"DataElement":{"publicId":"6400753","version":"1","preferredName":"Pharmacologic Substance Product Material Code ACT I2B2 CDM Medication Classification System Version Text","preferredDefinition":"An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).:The end result of a manufacturing process; anything that is produced.:The tangible substance that goes into the makeup of a physical object._A system of numbered categories for representation of data._Medication classification system version.","longName":"3760536v1.0:6399658v1.0","context":"CDMH","contextVersion":"1","DataElementConcept":{"publicId":"3760536","version":"1","preferredName":"Pharmacologic Substance Product Material Code","preferredDefinition":"An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).:The end result of a manufacturing process; anything that is produced.:The tangible substance that goes into the makeup of a physical object._A system of numbered categories for representation of data.","longName":"2867693v1.0:2222855v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2867693","version":"1","preferredName":"Pharmacologic Substance Product Material","preferredDefinition":"An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).:The end result of a manufacturing process; anything that is produced.:The tangible substance that goes into the makeup of a physical object.","longName":"C1909:C51980:C48187","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Product","conceptCode":"C51980","definition":"The end result of a manufacturing process; anything that is produced.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Material","conceptCode":"C48187","definition":"The tangible substance that goes into the makeup of a physical object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6941772E-ECAA-1039-E040-BB89AD437C46","latestVersionIndicator":"Yes","beginDate":"2009-05-06","endDate":null,"createdBy":"UMLLOADER_BRIDGPRD","dateCreated":"2009-05-06","modifiedBy":"ONEDATA","dateModified":"2009-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222855","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F621162F-5C48-4F85-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCA7E52E-7F9D-EFF5-E040-BB89AD431688","latestVersionIndicator":"Yes","beginDate":"2013-05-13","endDate":null,"createdBy":"UMLLOADER_BRIDGPRD","dateCreated":"2013-05-14","modifiedBy":"DWARZEL","dateModified":"2022-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6399658","version":"1","preferredName":"ACT I2B2 CDM Medication Classification System Version Text","preferredDefinition":"Medication classification system version.","longName":"6399658v1.0","context":"CDMH","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACT CDM:The Accrual to Clinical Trials Network Common Data Model","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7367D225-8549-1A6B-E053-F662850A97BC","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-14","modifiedBy":"COOPERM","dateModified":"2019-02-20","changeDescription":"Based on ACT I2B2 CDM.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6093471","version":"1.4","longName":"i2b2 ACT Network CDM 1.4","context":"CDMH","ClassificationSchemeItems":[{"publicId":"6093474","version":"1.4","longName":"Medication","context":"CDMH"}]}],"AlternateNames":[{"name":"MEDICATION_CLASSIFICATION_SYSTEM_VERSION","type":"ACT Name","context":"CDMH"},{"name":"MEDICATION","type":"ACT Table","context":"CDMH"}],"ReferenceDocuments":[{"name":"Medication Classification Sys","type":"Preferred Question Text","description":"Medication Classification System Version","url":null,"context":"CDMH"}],"origin":"ACT CDM:The Accrual to Clinical Trials Network Common Data Model","workflowStatus":"RELEASED","registrationStatus":"Application","id":"736FE0CD-A16B-06C6-E053-F662850A52EC","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-14","modifiedBy":"ONEDATA","dateModified":"2023-03-10","changeDescription":"Based on CDMH BRIDG 5.0.2 and i2b2 ACT value set for CDM. Removed table name and spaces from the alternate name. DW 11-07-2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}